![]() Virogenics Virogenics is a company that specializes in the research and development of gene therapies and stem cell technology. | ![]() Accure Therapeutics Accure Therapeutics is a company that develops a drug candidate portfolio in three programs (ACT-01, ACT-02, ACT-03) pursuing innovative targets that focus on four areas: Optic Neuritis, Multiple Sclerosis, Parkinson’s Disease, and Epilepsy. | ![]() Sudo Biosciences Sudo Biosciences is a biopharmaceutical company that creates medicines for patients. | Transition Bio Transition Bio is a biotechnology company that provides technologies for biomolecular condensate analysis. | ||
Founding Date | Founding Date 2003 | Founding Date 2020 | Founding Date 2020 | Founding Date 2020 | Founding Date 2015 |
Type | Type Private | Type Private | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations Barcelona, ES HQ | Locations Carmel, US HQ | Locations Cambridge, US HQ Cambridge, GB | Locations Waltham, US HQ |
Employees | Employees 4 | Employees N/A | Employees 24 | Employees 2915% decrease | Employees 76 |
Funding | |||||
Latest funding round | Latest funding round $ 6m (over 13 years ago) | Latest funding round $ 8.3m (almost 6 years ago) | Latest funding round $ 116m (over 2 years ago) | Latest funding round $ 50m (almost 4 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 6m | Total funding raised $ 8.3m | Total funding raised $ 153m | Total funding raised $ 50m | Total funding raised $ 131.5m |

Accure Therapeutics is a company that develops a drug candidate portfolio in three programs (ACT-01, ACT-02, ACT-03) pursuing innovative targets that focus on four areas: Optic Neuritis, Multiple Sclerosis, Parkinson’s Disease, and Epilepsy.
View company
Sudo Biosciences is a biopharmaceutical company that creates medicines for patients.
View companyTransition Bio is a biotechnology company that provides technologies for biomolecular condensate analysis.
View company
Morphic Therapeutic operates as a biotechnology company.
View company